Table IDisease-7. Incidence of hepatitis C virus antibody among injecting drug users
| Country | Year | Number of IDUs followed | Number of sero-conversions | Follow-up in person years | Incidence rate (per 100 person years) | Reference | |
| Germany | 1993-1994 | 19 | 6 | 17.5 | 34.3 | 11 | |
| Italy | 1991-1993 | 106 | 21 | 74.3 | 28.2 | 9 | |
| Italy | 1992-1993 | 34 | 2 | 32.1 | 6.2 | 10 | |
| Italy | 1992-1994 | 12 | 5 | 12.7 | 39.3 | 26 | |
| Netherlands | 1986-1989 | 18 | 17 | 207.8 | 8.2 | 22 | |
| Slovakia | 623 | na | na | 10 | 2 | ||
| Sweden | 1990-1993 | 48 | 27 | 103 | 26.3 | 6 | |
| Sources: | |||||||
| All data except for Slovak Republic were taken from: Roy K, Hay G, Andragetti R, Taylor A, Goldberg D, Wiessing L. Monitoring hepatitis C virus infection among injecting drug users in the European Union: a review of the literature. Epidemiol Infect 2002; 129: 577-585. | |||||||
| For references see [Table IDisease-0 Part (i)] | |||||||
